Skye BioscienceSKYE
13F holders, Q4 2025 (December 31)50holders −8
14new positions
23sold out
1famous investor
$0.75avg. 13F price*
At the end of Q4 2025, 50 institutions reported holding Skye Bioscience Inc. (SKYE) in their 13F filings, down 8 from Q3 2025. 14 opened new positions and 23 sold out. The largest holders were 5AM Venture Management, LLC ($7.3M), Versant Venture Management, LLC ($1.5M) and Baker Bros. Advisors LP ($1.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Skye Bioscience Inc.
- CUSIP
- 83086J200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $158K |
| Exits | 23 | $10.9M |
All 13F filers, Q3 2025 → Q4 2025: 242,804 shares bought and 3,994,397 shares sold, net −3,751,593 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 50 holders
| 5AM Venture Management, LLC | 2.28% | No change | 9,681,763 | $7.3M |
| Versant Venture Management, LLC | 1.00% | No change | 2,007,704 | $1.5M |
| Baker Bros. Advisors LP | 0.01% | No change | 1,450,638 | $1.1M |
| Vanguard Group Inc. | 0.00% | No change | 882,785 | $662K |
| Sphera Funds Management LTD. | 0.07% | No change | 478,928 | $359K |
| Millennium Management | 0.00% | Reduce -5.4% | 380,478 | $285K |
| BlackRock, Inc. | 0.00% | Add +0.7% | 281,841 | $211K |
| Platinum Investment Management Ltd. | 0.04% | No change | 233,095 | $175K |
| Geode Capital Management, LLC | 0.00% | Add +0.7% | 210,151 | $158K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -92.1% | 93,407 | $70K |
| State Street Corp. | 0.00% | No change | 75,326 | $56K |
| XTX Topco Ltd | 0.00% | New | 53,040 | $40K |
| Two Sigma Investments, LP | 0.00% | Reduce -44.0% | 51,706 | $39K |
| Two Sigma Advisers, LP | 0.00% | New | 40,982 | $31K |
| HRT Financial LP | 0.00% | New | 27,348 | $20K |
| Jane Street Group, LLC | 0.00% | Add +93.3% | 24,615 | $18K |
| Engineers Gate Manager LP | 0.00% | New | 23,138 | $17K |
| Gsa Capital Partners LLP | 0.00% | New | 22,877 | $17K |
| Barclays PLC | 0.00% | New | 21,251 | $16K |
| Northern Trust Corp. | 0.00% | Reduce -30.6% | 20,142 | $15K |
| Group One Trading LLC | 0.00% | Add +634.3% | 17,697 | $13K |
| R Squared Ltd | 0.01% | New | 14,782 | $11K |
| UBS Group AG | 0.00% | Reduce -55.7% | 13,286 | $10K |
| Capital Advisors Inc. | 0.00% | No change | 10,000 | $7K |
| Simplex Trading, LLC | 0.00% | New | 6,331 | $5K |
| Morgan Stanley | 0.00% | Reduce -13.8% | 4,269 | $3K |
| Federated Hermes, Inc. | 0.00% | New | 1,158 | $868 |
| FMR LLC | 0.00% | Reduce -93.7% | 748 | $561 |
| Bank of America Corp. | 0.00% | Add +315.6% | 586 | $438 |
| BNP Paribas Financial Markets | 0.00% | No change | 510 | $382 |
| National Bank of Canada | 0.00% | New | 400 | $295 |
| Fortitude Family Office, LLC | 0.00% | Add +237.7% | 385 | $289 |
| JPMorgan Chase & Co. | 0.00% | New | 66 | $49 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | Reduce -99.8% | 52 | $39 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 51 | $38 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 39 | $29 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 25 | $18 |
| Optiver Holding B.V. | 0.00% | No change | 20 | $15 |
| NFSG Corp | 0.00% | No change | 18 | $13 |
| Dynamic Wealth Strategies, LLC | 0.00% | New | 8 | $6 |
| CoreCap Advisors, LLC | 0.00% | New | 8 | $6 |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 3 | $2 |
| McGuire Capital Advisors Inc. | 0.00% | — | 2 | $2 |
| Wells Fargo & Company | 0.00% | No change | 1 | $1 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $1 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $1 |
| Osaic Holdings, Inc. | 0.00% | Reduce -88.9% | 2 | $1 |
| Tucker Asset Management LLC | 0.00% | New | 1 | $1 |
| PFS Partners, LLC | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -69.1% | 124 | $0 |
"% of holder's portfolio" is SKYE's weight in each manager's 13F, not the share of Skye Bioscience Inc. the manager owns.